Maven Health
Lausanne
About Maven Health
Maven Health operates a B2B2C model with healthcare professionals like clinics and registered nutritionists as customers. The core product is the non-invasive saliva metabolite test, measuring 47 metabolites ranging from amino acids to short-chain fatty acids. These are critical parameters to assess metabolic health. It is used in small practices or clinics, standalone or in tandem with other tests (genetic, gut microbiome etc.). Maven Health is an asset-light model and does not own or operate the hardware (nuclear magnetic resonance). We currently operate in CH, NL and are expanding to other European countries. We are looking for starting pilots in the USA late 2025.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $510.8K
- Funding stage: Seed
- Last round: Grant (Feb 2024)
- Website: mavenhealth.chen
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Health Care
Social Profiles
Canonical: https://fsome.com/organization/maven-health-3243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.